Workflow
太龙药业: 太龙药业关于为下属全资及控股子公司融资提供担保的进展公告

Core Viewpoint - The announcement details the provision of guarantees by the company for its wholly-owned and controlling subsidiaries, aimed at supporting their financing needs and promoting business development [1][5]. Summary by Sections Guarantee Overview - The company has provided a guarantee of RMB 6.8 million for its wholly-owned subsidiary, Zhejiang Tongjuntang Traditional Chinese Medicine Co., Ltd., and a guarantee of RMB 4 million for its controlling subsidiary, New Leading (Chongqing) Pharmaceutical Technology Co., Ltd. [1] - The total actual guarantee balance for Zhejiang Tongjuntang is RMB 145 million (including this guarantee), and for Chongqing New Leading, it is RMB 13.57 million (including this guarantee) [1]. Approval Process - The company held board meetings on April 7, 2025, and April 29, 2025, to approve the provision of guarantees for the fiscal year 2025 [2]. - The company adjusted the unused guarantee quota of RMB 40 million from its subsidiary, Zhejiang Tongjuntang, to another subsidiary, Tongjuntang [2]. Financial Status of Guaranteed Entities - Zhejiang Tongjuntang Traditional Chinese Medicine Co., Ltd. has total assets of RMB 492.19 million and total liabilities of RMB 293.63 million, with a net profit of RMB 55.30 million [4]. - New Leading (Chongqing) Pharmaceutical Technology Co., Ltd. has total assets of RMB 25.75 million and total liabilities of RMB 11.99 million, with a net asset value of RMB 13.76 million [4]. Necessity and Reasonableness of Guarantees - The guarantees are deemed necessary to meet the operational and financing needs of the subsidiaries, aligning with the company's development strategy [5]. - The financial condition of the guaranteed entities is stable, and the overall risk is controllable, ensuring no significant impact on the company's daily operations [5]. Board Opinion - The board believes that the guarantees will enhance financing efficiency, reduce costs, and support sustainable business development, considering the subsidiaries' financial stability and creditworthiness [5]. External Guarantee Status - As of the announcement date, the company has no overdue guarantees and maintains a total external guarantee balance without any overdue items [6].